Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Eschner

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Zeitschrift Fur Medizinische Physik|May 16, 2006
[Image reconstruction and quantification in emission tomography]Michael Mix, Wolfgang Eschner
Human Molecular Genetics|October 29, 2013
Inferring primary tumor sites from mutation spectra: a meta-analysis of histology-specific aberrations in cancer-derived cell linesFelix Dietlein, Wolfgang Eschner
Zeitschrift Fur Medizinische Physik|July 2, 2011
Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?Wolfgang Eschner, Carsten Kobe, Harald Schicha
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2009
PROLARA: prognosis-based lifetime attributable risk approximation for cancer from diagnostic radiation exposureWolfgang Eschner, Matthias Schmidt, Markus Dietlein, et al.
Zeitschrift Fur Medizinische Physik|August 25, 2004
[Calibration of a whole body counter using Monte Carlo methods]Bastian Breustedt, Hans Paetz gen Schieck, Harald Schicha, et al.
Zeitschrift Fur Medizinische Physik|October 11, 2011
GATE based Monte Carlo simulation of planar scintigraphy to estimate the nodular dose in radioiodine therapy for autonomous thyroid adenomaJochen Hammes, Uwe Pietrzyk, Matthias Schmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2010
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paragangliomaFerdinand Sudbrock, Matthias Schmidt, Thorsten Simon, et al.
Nuklearmedizin. Nuclear Medicine|June 29, 2016
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4]Markus Dietlein, Wolfgang Eschner, Frank Grünwald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2013
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseasesHeribert Hänscheid, Cristina Canzi, Wolfgang Eschner, et al.
Thyroid : Official Journal of the American Thyroid Association|March 31, 2006
Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid diseaseMatthias Schmidt, Eva Gorbauch, Markus Dietlein, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Zeitschrift Fur Medizinische Physik|May 16, 2006
[Image reconstruction and quantification in emission tomography]Michael Mix, Wolfgang Eschner
Human Molecular Genetics|October 29, 2013
Inferring primary tumor sites from mutation spectra: a meta-analysis of histology-specific aberrations in cancer-derived cell linesFelix Dietlein, Wolfgang Eschner
Zeitschrift Fur Medizinische Physik|July 2, 2011
Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?Wolfgang Eschner, Carsten Kobe, Harald Schicha
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2009
PROLARA: prognosis-based lifetime attributable risk approximation for cancer from diagnostic radiation exposureWolfgang Eschner, Matthias Schmidt, Markus Dietlein, et al.
Zeitschrift Fur Medizinische Physik|August 25, 2004
[Calibration of a whole body counter using Monte Carlo methods]Bastian Breustedt, Hans Paetz gen Schieck, Harald Schicha, et al.
Zeitschrift Fur Medizinische Physik|October 11, 2011
GATE based Monte Carlo simulation of planar scintigraphy to estimate the nodular dose in radioiodine therapy for autonomous thyroid adenomaJochen Hammes, Uwe Pietrzyk, Matthias Schmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2010
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paragangliomaFerdinand Sudbrock, Matthias Schmidt, Thorsten Simon, et al.
Nuklearmedizin. Nuclear Medicine|June 29, 2016
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4]Markus Dietlein, Wolfgang Eschner, Frank Grünwald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2013
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseasesHeribert Hänscheid, Cristina Canzi, Wolfgang Eschner, et al.
Thyroid : Official Journal of the American Thyroid Association|March 31, 2006
Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid diseaseMatthias Schmidt, Eva Gorbauch, Markus Dietlein, et al.
Pageof 3